Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
Clinical trial NCT03387904 · UNKNOWN
Trial details
- NCT number
- NCT03387904
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-13
- Primary completion
- 2021-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.